Richard Armitage

6.5k total citations · 3 hit papers
82 papers, 3.2k citations indexed

About

Richard Armitage is a scholar working on General Health Professions, Public Health, Environmental and Occupational Health and Clinical Psychology. According to data from OpenAlex, Richard Armitage has authored 82 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in General Health Professions, 14 papers in Public Health, Environmental and Occupational Health and 12 papers in Clinical Psychology. Recurrent topics in Richard Armitage's work include Artificial Intelligence in Healthcare and Education (12 papers), T-cell and B-cell Immunology (8 papers) and Immune Cell Function and Interaction (7 papers). Richard Armitage is often cited by papers focused on Artificial Intelligence in Healthcare and Education (12 papers), T-cell and B-cell Immunology (8 papers) and Immune Cell Function and Interaction (7 papers). Richard Armitage collaborates with scholars based in United Kingdom, United States and Germany. Richard Armitage's co-authors include William C. Fanslow, Laura B Nellums, David Cosman, Marek Kubin, Wilson Chin, Jürgen Müllberg, Claire L. Sutherland, N. Jan Chalupny, Bo Ruem Yoon and Molly D. Smithgall and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Cell Biology and Immunity.

In The Last Decade

Richard Armitage

60 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ULBPs, Novel MHC Class I–Related Molecules, Bind to CMV Glycoprotein UL16 and Stimulate NK Cytotoxicity through the NKG2D Receptor

2001 982 citations Richard Armitage, William C. Fanslow et al. profile →
IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK Cells

2008 516 citations Molly D. Smithgall, Michael R. Comeau et al. International Immunology profile →
Bullying in children: impact on child health

2021 159 citations Richard Armitage profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard Armitage United Kingdom	19	2.0k	486	317	304	240	82	3.2k
Steven Friedman United States	37	1.7k 0.8×	559 1.2×	349 1.1×	204 0.7×	640 2.7×	160	4.5k
Carol M. Lewis United States	28	355 0.2×	679 1.4×	214 0.7×	975 3.2×	460 1.9×	107	3.3k
Susan J. Thorpe United Kingdom	32	773 0.4×	349 0.7×	175 0.6×	207 0.7×	975 4.1×	98	4.9k
Kathleen Doherty Australia	24	537 0.3×	225 0.5×	153 0.5×	44 0.1×	274 1.1×	96	2.4k
David R. Karp United States	44	2.6k 1.3×	370 0.8×	529 1.7×	958 3.2×	982 4.1×	153	6.2k
Xiang Zhou China	24	1.8k 0.9×	269 0.6×	280 0.9×	121 0.4×	1.4k 5.7×	61	2.9k
Wei Song China	25	404 0.2×	245 0.5×	526 1.7×	58 0.2×	221 0.9×	132	2.6k
Diana Chen United States	23	278 0.1×	86 0.2×	243 0.8×	215 0.7×	230 1.0×	104	3.4k
John Sharp United States	28	407 0.2×	753 1.5×	179 0.6×	464 1.5×	1.1k 4.5×	230	3.9k
Robert Chin United States	36	1.9k 0.9×	1.6k 3.2×	392 1.2×	763 2.5×	491 2.0×	190	5.8k

Countries citing papers authored by Richard Armitage

Since Specialization

Citations

This map shows the geographic impact of Richard Armitage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Armitage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Armitage more than expected).

Fields of papers citing papers by Richard Armitage

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Armitage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Armitage. The network helps show where Richard Armitage may publish in the future.

Co-authorship network of co-authors of Richard Armitage

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Armitage. A scholar is included among the top collaborators of Richard Armitage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Armitage. Richard Armitage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Armitage, Richard. (2026). The unresolved ethics of trading patient trust for environmental sustainability. 2(1). e000084–e000084.

Armitage, Richard. (2025). On Medical Tourism Overseas: Ethical Analysis of the Duties of NHS Doctors in Managing the Negative Health Consequences of Accessing Medical Treatments Abroad. Journal of Evaluation in Clinical Practice. 31(1). e14300–e14300.

Armitage, Richard. (2025). How do GPs Want Large Language Models to be Applied in Primary Care, and What Are Their Concerns? A Cross‐Sectional Survey. Journal of Evaluation in Clinical Practice. 31(4). e70129–e70129.

Armitage, Richard. (2024). Is it ethically permissible for GPs to promote non-directed altruistic kidney donation to healthy adults?. Journal of Medical Ethics. jme–2023. 1 indexed citations

Armitage, Richard. (2024). Books:Good Reasons for Bad Feelings: Insights from the Frontier of Evolutionary Psychiatry. British Journal of General Practice. 74(747). 465–466. 1 indexed citations

Armitage, Richard. (2024). On interpreters: the ethics of interpreter use in general practice. Journal of Medical Ethics. 51(9). jme–2024. 2 indexed citations

Armitage, Richard. (2024). Books:Magic Pill: The Extraordinary Benefits and Disturbing Risks of the New Weight Loss Drugs. British Journal of General Practice. 74(745). 371–371. 1 indexed citations

Armitage, Richard. (2024). Implications of Large Language Models for Clinical Practice: Ethical Analysis Through the Principlism Framework. Journal of Evaluation in Clinical Practice. 31(1). e14250–e14250. 11 indexed citations

Armitage, Richard. (2024). Generative AI in medical writing: co-author or tool?. British Journal of General Practice. 74(740). 126–127.

10.

Armitage, Richard. (2023). The WHO’s definition of health: a baby to be retrieved from the bathwater?. British Journal of General Practice. 73(727). 70–71. 1 indexed citations

11.

Armitage, Richard. (2023). ChatGPT: the threats to medical education. Postgraduate Medical Journal. 99(1176). 1130–1131. 15 indexed citations

12.

Armitage, Richard. (2023). General practice in the UK’s response to the Türkiye and Syrian earthquakes. British Journal of General Practice. 73(730). 218–219.

13.

Armitage, Richard. (2023). Why we must stop ‘consenting the patient’. British Journal of General Practice. 73(731). 268–269.

14.

Armitage, Richard. (2022). Gender markers, patient records, and population screening programmes: A threat to trans patient care quality. Public Health in Practice. 3. 100238–100238.

15.

Armitage, Richard. (2021). Physical health checks for people with severe mental illness during COVID-19. British Journal of General Practice. 71(705). 171–171. 4 indexed citations

16.

Armitage, Richard & Laura B Nellums. (2020). Emerging from COVID-19: prioritising the burden of loneliness in older people. British Journal of General Practice. 70(697). 382.2–382. 5 indexed citations

17.

Smithgall, Molly D., Michael R. Comeau, Bo Ruem Yoon, et al.. (2008). IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK Cells. International Immunology. 20(8). 1019–1030. 516 indexed citations breakdown →

18.

Armitage, Richard. (1997). DOES DIAL-A-RIDE HAVE A FUTURE?. 1 indexed citations

19.

Younes, Anas, Ugo Consoli, Virginia Snell, et al.. (1997). CD30 ligand in lymphoma patients with CD30+ tumors.. Journal of Clinical Oncology. 15(11). 3355–3362. 48 indexed citations

20.

Maliszewski, Charles R., Kenneth H. Grabstein, William C. Fanslow, et al.. (1993). Recombinant CD40 ligand stimulation of murine B cell growth and differentiation: cooperative effects of cytokines. European Journal of Immunology. 23(5). 1044–1049. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact